{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:33:14Z","timestamp":1793075594847,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006282","name":"Fondation Roi Baudouin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008313","name":"Association Jules Bordet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013845","name":"Fondation contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013845","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005026","name":"Fondation contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015230","name":"Fondation Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofliquidbiopsy.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Liquid Biopsy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jlb.2026.100492","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:33:26Z","timestamp":1788222806000},"page":"100492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cerebrospinal fluid circulating tumor DNA profiling in central nervous system metastases from solid tumors: A prospective multicentre translational analysis of the BrainStorm (OncoDistinct-006) study"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3818-0364","authenticated-orcid":false,"given":"Luca","family":"Arecco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Roth\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Venet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gombos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"De Maio D'Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Barth\u00e9l\u00e9my","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Vanhaudenarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Clatot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Holbrechts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois P.","family":"Duhoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Borcoman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Cheymol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Gligorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore","family":"Denys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Punie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Duhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lore","family":"Decoster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Canon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Lefranc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Rasschaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Kindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"\u010cular","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristanto","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Delaroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro","family":"de Azambuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Awada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Kotecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlb.2026.100492_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approaches to the management of brain metastases","volume":"17","author":"Suh","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib2","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/neuonc\/noac118","article-title":"Brain metastases: a society for neuro-oncology (SNO) consensus review on current management and future directions","volume":"24","author":"Aizer","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdw532","article-title":"Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives","volume":"28","author":"Costa","year":"2017","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib4","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104276","article-title":"The treatment of advanced melanoma: current approaches and new challenges","volume":"196","author":"Boutros","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jlb.2026.100492_bib6","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11060-025-05190-y","article-title":"CACHO (Central nervous system activity in cancer and hemato-oncologic diseases) network, real-world experience outcome in patients with central nervous system metastases: information on 2,226 patients during a 15-year period","volume":"175","author":"Arrieta","year":"2025","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41582-020-0391-x","article-title":"Management of brain metastases according to molecular subtypes","volume":"16","author":"Soffietti","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jlb.2026.100492_bib8","article-title":"Impact of brain metastases on quality of life and estimated life expectancy in patients with advanced non-small cell lung cancer","volume":"17","author":"Roughley","year":"2014","journal-title":"Value Health J Int Soc Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.jlb.2026.100492_bib9","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/neuonc\/noae103","article-title":"Leptomeningeal metastases from solid tumors: a society for neuro-oncology and American society of clinical oncology consensus review on clinical management and future directions","volume":"26","author":"Wilcox","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1523069","article-title":"Analysis of prognostic factors and risk prediction in brain metastases: a SEER population-based study","volume":"15","author":"Ji","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib11","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jlb.2026.100492_bib12","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41571-023-00808-4","article-title":"Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancer","volume":"20","author":"Pan","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib13","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1038\/s41591-024-03261-7","article-title":"DESTINY-Breast12 study group, trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b\/4 trial","volume":"30","author":"Harbeck","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jlb.2026.100492_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jamaoncol.2022.5610","article-title":"Tucatinib vs placebo, both in combination with trastuzumab and capecitabine, for previously treated ERBB2 (HER2)-positive metastatic breast cancer in patients with brain metastases: updated exploratory analysis of the HER2CLIMB randomized clinical trial","volume":"9","author":"Lin","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib15","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1200\/JCO.21.02278","article-title":"Post hoc analysis of lorlatinib intracranial efficacy and safety in patients with ALK-positive advanced Non\u2013small-cell lung cancer from the phase III CROWN study","volume":"40","author":"Solomon","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in Melanoma metastatic to the brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jlb.2026.100492_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41568-019-0220-y","article-title":"Brain metastasis","volume":"20","author":"Boire","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jlb.2026.100492_bib18","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41416-023-02446-0","article-title":"Liquid biopsy: creating opportunities in brain space","volume":"129","author":"Trivedi","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jlb.2026.100492_bib19","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/jamainternmed.2023.3603","article-title":"Assessing the clinical utility of liquid biopsies across 5 potential indications from therapy selection to population screening: a review","volume":"183","author":"Carr","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jlb.2026.100492_bib20","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1200\/JCO.23.02112","article-title":"US food and drug administration approval summary: elacestrant for Estrogen Receptor-positive, human epidermal growth factor receptor 2-Negative, ESR1-Mutated advanced or metastatic breast cancer","volume":"42","author":"Shah","year":"2024","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib21","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1200\/JCO.24.00427","article-title":"US food and drug administration approval summary: capivasertib with fulvestrant for hormone Receptor-positive, human epidermal growth factor receptor 2-Negative locally advanced or metastatic breast cancer with PIK3CA\/AKT1\/PTEN alterations","volume":"42","author":"Dilawari","year":"2024","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41416-022-01776-9","article-title":"Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges","volume":"127","author":"Garc\u00eda-Pardo","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jlb.2026.100492_bib23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41698-025-00876-y","article-title":"Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology","volume":"9","author":"Bartolomucci","year":"2025","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib24","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1093\/brain\/awad195","article-title":"The coming of age of liquid biopsy in neuro-oncology","volume":"146","author":"Berzero","year":"2023","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.jlb.2026.100492_bib25","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1038\/ncomms9839","article-title":"Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma","volume":"6","author":"De Mattos-Arruda","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jlb.2026.100492_bib26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12916-022-02595-8","volume":"20","author":"Li","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.jlb.2026.100492_bib27","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41591-025-03538-5","article-title":"Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases","volume":"31","author":"Zheng","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.jlb.2026.100492_bib28","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1038\/s41591-023-02595-y","article-title":"BrainStorm: a multicenter international study to tackle CNS metastases in solid tumors","volume":"29","author":"Martins-Branco","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jlb.2026.100492_bib29","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1200\/JCO.2016.66.6487","article-title":"Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid","volume":"34","author":"Pentsova","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib30","doi-asserted-by":"crossref","DOI":"10.1200\/PO-24-00921","article-title":"Minimum technical preanalytical, patient, and clinical context data elements for cerebrospinal fluid liquid biopsy: recommendations for public database submissions","author":"Bagley","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41586-019-1056-z","article-title":"Genomic characterization of metastatic breast cancers","volume":"569","author":"Bertucci","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jlb.2026.100492_bib32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41698-024-00761-0","article-title":"Breast cancer brain metastases genomic profiling identifies alterations targetable by immune-checkpoint and PARP inhibitors","volume":"8","author":"Giannoudis","year":"2024","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/bjc.2011.464","article-title":"High frequency of complex TP53 mutations in CNS metastases from breast cancer","volume":"106","author":"Lo Nigro","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jlb.2026.100492_bib34","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1158\/1078-0432.CCR-13-2943","article-title":"TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance","volume":"20","author":"Silwal-Pandit","year":"2014","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.jlb.2026.100492_bib35","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1038\/s41467-023-43242-x","article-title":"Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype","volume":"14","author":"Fitzpatrick","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jlb.2026.100492_bib36","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.15250","article-title":"Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis","volume":"11","author":"Congur","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.jlb.2026.100492_bib37","article-title":"Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations","volume":"8","author":"Brown","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jlb.2026.100492_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02903-x","article-title":"Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors","volume":"11","author":"Thulin","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jlb.2026.100492_bib39","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/1878-0261.13357","article-title":"Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC","volume":"17","author":"Wu","year":"2023","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/annonc\/mdy544","article-title":"Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases","volume":"30","author":"Seoane","year":"2019","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib41","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1038\/s41467-022-35245-x","article-title":"Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer","volume":"13","author":"Sivakumar","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jlb.2026.100492_bib42","article-title":"Longitudinal shifts of solid tumor and liquid biopsy sequencing concordance in metastatic breast cancer","volume":"6","author":"Liu","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41698-024-00582-1","article-title":"Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis","volume":"8","author":"Azad","year":"2024","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib44","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdy009","article-title":"Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy","volume":"29","author":"Li","year":"2018","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.jlb.2026.100492_bib45","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1038\/s41467-018-06715-y","article-title":"Epigenetic profiling for the molecular classification of metastatic brain tumors","volume":"9","author":"Orozco","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jlb.2026.100492_bib46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41591-024-03286-y","article-title":"Prediction of brain metastasis development with DNA methylation signatures","volume":"31","author":"Zuccato","year":"2025","journal-title":"Nat Med"}],"container-title":["The Journal of Liquid Biopsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295019542600038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295019542600038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:01:04Z","timestamp":1793073664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S295019542600038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":46,"alternative-id":["S295019542600038X"],"URL":"https:\/\/doi.org\/10.1016\/j.jlb.2026.100492","relation":{},"ISSN":["2950-1954"],"issn-type":[{"value":"2950-1954","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid circulating tumor DNA profiling in central nervous system metastases from solid tumors: A prospective multicentre translational analysis of the BrainStorm (OncoDistinct-006) study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Liquid Biopsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlb.2026.100492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of The International Society of Liquid Biopsy.","name":"copyright","label":"Copyright"}],"article-number":"100492"}}